A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy
暂无分享,去创建一个
Masaaki Nakamura | Y. Ando | H. Tanihara | E. Ando | A. Hirata | T. Kawaji
[1] J. Garcia-Arumi,et al. Vitreous amyloidosis without systemic or familial involvement , 2004, International Ophthalmology.
[2] A. Negi,et al. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. , 2003, American journal of ophthalmology.
[3] Y. Ando,et al. Ocular amyloid involvement after liver transplantation for polyneuropathy. , 2001, Annals of internal medicine.
[4] M. Saraiva,et al. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: Ocular synthesis of mutant transthyretin , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[5] Y. Ando,et al. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[6] A. Negi,et al. Ocular manifestations of familial amyloidotic polyneuropathy type I: long term follow up , 1997, The British journal of ophthalmology.
[7] M. Skinner,et al. A new transthyretin mutation associated with amyloidotic vitreous opacities. Asparagine for isoleucine at position 84. , 1992, Ophthalmology.
[8] E. Schon,et al. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. , 1990, Investigative ophthalmology & visual science.
[9] G. Holmgren,et al. Restriction fragment length polymorphism analysis of mutated transthyretin in vitreous amyloidosis. , 1988, Archives of ophthalmology.
[10] E. Schon,et al. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. , 1985, The Journal of biological chemistry.